Read on Twitter
1-9 #Immunology #IDTwitter #Cellimmunity #Viralimmunity #cardiotwitter #Clinicalperspective Increasing data demonstrate that women mount stronger #immuneresponses against #SARSCoV2 than males https://www.sciencedirect.com/science/article/pii/S1074761320303368#fig1 @CellPressNews @vass_vassiliou @mmamas1973 @DocSavageTJU
2 #Globalhealth #Casereport Understand- ing sex differences of cardiac manifestations in COVID-19 disease should not be optional https://casereports.onlinejacc.org/content/jacccr/2/9/1407.full.pdf
3 Significantly milder illness and fewer deaths were found in female COVID-19 inpatients and risk factors associated with mortality varied among males and females https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa920/5868544 @OUPAcademic
4 Considering the impact of the gender on the COVID-19 epidemic, even if confirmed cases from each nation are changing every day, epidemiological data clearly evidence that in men the infection causes worse outcomes compared to women https://www.sciencedirect.com/science/article/pii/S0306987720315334 @sciencedirect
5 Data from Istituto Superiore di SanitĆ (ISS, Italy) show that more than 68.3% of patients had hypertension, 28.2% ischemic heart disease, 22.5% atrial fibrillation, while 30.1% T2DM.All are linked to endothelial dysfunction, and all of them are strictly related to aging
6 Cardiovascular complications are rapidly emerging as a key threat in #COVID19 in addition to respiratory disease .The mechanisms underlying the disproportionate effect of #SARSCoV2 infection on patients with #CVD https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30937-5/fulltext?utm_campaign=tlcoronavirus20&utm_source=twitter&utm_medium=social @TheLancet
7 The 31% incidence of thrombotic complications in ICU patients with COVID-19 infections is remarkably high. Our findings reinforce the recommendation to strictly apply pharmacological thrombosis prophylaxis in all COVID-19 patients admitted to the ICU https://www.sciencedirect.com/science/article/pii/S0049384820301201
8 This #Clinicalreview analysis, therefore, concentrates primarily on recent discoveries related to #COVID19 #pathogenesis along with a full description of the structure, #genome,& secondary complication associated with #SARSCoV2 https://www.sciencedirect.com/science/article/pii/S0024320520308560 @sciencedirect
9 #AngiotensinconvertingEnzymeInhibitor/ #AngiotensinReceptorBlocker Use and #COVID19: Time to Change Practice or Keep Gathering Data?https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa819/5867490
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa677/5867535 @OUPAcademic
#COVID19 in the 
of the matters -At this relatively early stage of the pandemic, the accumulation of data, though substantial, has yet to change practice recommendations. One might conclude that the currently limited knowledge in the matter has provided more ??? than answers.
of the matters -At this relatively early stage of the pandemic, the accumulation of data, though substantial, has yet to change practice recommendations. One might conclude that the currently limited knowledge in the matter has provided more ??? than answers.
Nevertheless, studies like the one commented here are worthy investments as they enhance medical understanding of the disease, which may impact clinical decision-making in the near future.
